189 related articles for article (PubMed ID: 14989602)
21. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
[TBL] [Abstract][Full Text] [Related]
22. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
Koo KYG; Schweizer TA; Fischer CE; Munoz DG
Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease.
Ishunina TA; Swaab DF
Neurobiol Aging; 2001; 22(3):417-26. PubMed ID: 11378248
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
25. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
27. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
30. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
31. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
[TBL] [Abstract][Full Text] [Related]
32. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.
Stopa EG; Butala P; Salloway S; Johanson CE; Gonzalez L; Tavares R; Hovanesian V; Hulette CM; Vitek MP; Cohen RA
Stroke; 2008 Mar; 39(3):814-21. PubMed ID: 18258839
[TBL] [Abstract][Full Text] [Related]
33. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke.
Fekih-Mrissa N; Klai S; Mrad M; Mansour M; Zaouali J; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):681-5. PubMed ID: 23871727
[TBL] [Abstract][Full Text] [Related]
35. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
37. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.
Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
Dement Geriatr Cogn Disord; 1999; 10(4):252-7. PubMed ID: 10364641
[TBL] [Abstract][Full Text] [Related]
38. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
39. Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus.
Lucassen PJ; Ravid R; Gonatas NK; Swaab DF
Brain Res; 1993 Dec; 632(1-2):105-13. PubMed ID: 8149218
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype.
Glöckner F; Ohm TG
Neuroscience; 2003; 122(1):103-10. PubMed ID: 14596852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
